본문 바로가기
KERD
논문KCI 등재

COVID-19 치료 및 진단을 위한 Exosome의 임상적 적용

Clinical Application of Exosomes for COVID-19 and Diagnosis

June Seok HEO
대한임상검사과학회 (Korean Society for Clinical Laboratory Science)|2024.03|대한임상검사과학회지 (Korean Journal of Clinical Laboratory Science)|제56권 제1호|pp. 1-9|DOI 10.15324/kjcls.2024.56.1.1

0

조회

0

다운로드

0

인용

0

참고문헌

키워드

DiagnosisExosomeCell- and tissue-based therapyTherapeutics
주제분류기타자연과학

초록

엑소좀은 나노 크기의 세포외 소포체로 핵산, 단백질, 지질 등다양한 생리활성 물질을 함유하고 있다. 엑소좀의 생리활성 물질들은 주변 세포나 조직으로 전달될 수 있을 뿐만 아니라 기원된 세포의 고유 특정 물질들을 지니고 있기 때문에 엑소좀 유래물질들은 진단 및 치료를 위한 도구로 광범위하게 사용될 수 있음이 입증되고 있으며, 이러한 이유로 엑소좀은 진단을 위한 바이오마커, 약물 전달을 위한 운반체 및 치료제로 활용될 수 있는가능성에 많은 연구자들의 관심이 높아지고 있다. 줄기세포 분야에서 엑소좀은 줄기세포를 기반으로 한 비세포 치료제로서 보다 안전한 치료제로 사용될 수 있다는 점에서 매력적인 소재가되고 있으며, 최근에는 중간엽줄기세포 유래 엑소좀이 항염증및 면역조절능이 있어 코로나-19 증상 완화 효능에 대한 안전성과 효능이 입증되기도 했다. 이렇게 계속적인 엑소좀에 대한 축적된 연구는 임상 진단 및 치료를 위한 차세대 혁신적 결과물들을 제공할 것으로 생각되며, 이 종설에서는 엑소좀의 다양한 가치에 초점을 두고 미래의학의 강력한 도구로 어떻게 활용될 수있는지에 대한 엑소좀의 잠재력을 살펴보고자 한다.

Abstract

Exosomes are nano-sized membrane-bound extracellular vesicles containing various biological molecules, such as nucleic acids, proteins, and lipids, which can be used to modulate physiological processes. The exosomal molecules secreted by cells can be extensively used as tools for diagnosis and therapy. Exosomes carry specific molecules released by the cells they originate from, which can be transferred to surrounding cells or tissues by the exosome. For these reasons, exosomes can be exploited as biomarkers for diagnosis, carriers for drug delivery, as well as therapeutics. In stem cell technology, exosomes have been an attractive option because they can be used as safer therapeutic agents for stem cell-based cell-free therapy. Recently, studies have demonstrated the safety and efficacy of mesenchymal stem cell-derived exosomes in alleviating symptoms associated with coronavirus disease 2019 as they have anti-inflammatory and immunomodulatory potential. Performing multiple studies on exosomes would provide innovative next-generation options for clinical diagnostics and therapy. This review summarizes the use of exosomes focusing on their diverse roles. In addition, the potential of exosomes is illustrated with a focus on how exosomes can be exploited as powerful tools in the days to come.

참고문헌 (60)

  1. Hessvik NP, "Current knowledge on exosome biogenesis and release", Cell Mol Life Sci, 75, pp.193~208 (2018)[DOI]
  2. Raposo G, "Extracellular vesicles : exosomes, microvesicles, and friends", J Cell Biol, 200, pp.373~383 (2013)[DOI]
  3. Wolf P, "The nature and significance of platelet products in human plasma", Br J Haematol, 13, pp.269~288 (1967)[DOI]
  4. Baixauli F, "Exosomes and autophagy : coordinated mechanisms for the maintenance of cellular fitness", Front Immunol, 5, pp.403~ (2014)[DOI]
  5. Hessvik NP, "PIKfyve inhibition increases exosome release and induces secretory autophagy", Cell Mol Life Sci, 73, pp.4717~4737 (2016)[DOI]
  6. Johnstone RM, "Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes)", J Biol Chem, 262, pp.9412~9420 (1987)[DOI]
  7. Mathivanan S, "Exosomes : extracellular organelles important in intercellular communication", J Proteomics, 73, pp.1907~1920 (2010)[DOI]
  8. Record M, "Exosomes as new vesicular lipid transporters involved in cell-cell communication and various pathophysiologies", Biochim Biophys Acta, 1841, pp.108~120 (2014)[DOI]
  9. Hodgkinson CP, "Emerging concepts in paracrine mechanisms in regenerative cardiovascular medicine and biology", Circ Res, 118, pp.95~107 (2016)[DOI]
  10. Ratajczak MZ, "Pivotal role of paracrine effects in stem cell therapies in regenerative medicine : can we translate stem cell-secreted paracrine factors and microvesicles into better therapeutic strategies?", Leukemia, 26, pp.1166~1173 (2012)[DOI]
  11. Toma C, "Fate of culture-expanded mesenchymal stem cells in the microvasculature : in vivo observations of cell kinetics", Circ Res, 104, pp.398~402 (2009)[DOI]
  12. Jeppesen DK, "Reassessment of exosome composition", Cell, 177, pp.428~445 (2019)[DOI]
  13. Yang XX, "New insight into isolation, identification techniques and medical applications of exosomes", J Control Release, 308, pp.119~129 (2019)[DOI]
  14. Frühbeis C, "Neurotransmitter-triggered transfer of exosomes mediates oligodendrocyte-neuron communication", PLoS Biol, 11, pp.e1001604~ (2013)[DOI]
  15. Korkut C, "Trans-synaptic transmission of vesicular Wnt signals through Evi", Wntless, 2009, pp.139, 393~404
  16. Machtinger R, "Extracellular vesicles : roles in gamete maturation, fertilization and embryo implantation", Hum Reprod Update, 22, pp.182~193 (2016)[DOI]
  17. Raposo G, "B lymphocytes secrete antigen-presenting vesicles", J Exp Med, 183, pp.1161~1172 (1996)[DOI]
  18. Robbins PD, "Regulation of immune responses by extracellular vesicles", Nat Rev Immunol, 14, pp.195~208 (2014)[DOI]
  19. Ailawadi S, "Pathologic function and therapeutic potential of exosomes in cardiovascular disease", Biochim Biophys Acta, 1852, pp.1~11 (2015)[DOI]
  20. Kadiu I, "Biochemical and biologic characterization of exosomes and microvesicles as facilitators of HIV-1 infection in macrophages", J Immunol, 189, pp.744~754 (2012)[DOI]
  21. Kulshreshtha A, "Proinflammatory role of epithelial cell-derived exosomes in allergic airway inflammation", J Allergy Clin Immunol, 131, pp.1194~1203 (2013)[DOI]
  22. Skog J, "Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers", Nat Cell Biol, 10, pp.1470~1476 (2008)[DOI]
  23. György B, "Membrane vesicles, current state-of-the-art : emerging role of extracellular vesicles", Cell Mol Life Sci, 68, pp.2667~2688 (2011)[DOI]
  24. Heo JS, "Mesenchymal stem cell-derived exosomes : applications in cell-free therapy", Korean J Clin Lab Sci, 50, pp.391~398 (2018)[DOI]
  25. Zhang X, "Exosomes in cancer : small particle, big player", J Hematol Oncol, 8, pp.83~ (2015)[DOI]
  26. Keller S, "Body fluid derived exosomes as a novel template for clinical diagnostics", J Transl Med, 9, pp.86~ (2011)[DOI]
  27. He C, "Exosome theranostics : biology and translational medicine", Theranostics, 8, pp.237~255 (2018)[DOI]
  28. Gupta A, "Mesenchymal stem cells and exosome therapy for COVID-19 : current status and future perspective", Hum Cell, 33, pp.907~918 (2020)[DOI]
  29. Yuan Y, "The development of COVID-19 treatment", Front Immunol, 14, pp.1125246~ (2023)[DOI]
  30. Chu M, "Nebulization therapy with umbilical cord mesenchymal stem cell-derived exosomes for COVID-19 pneumonia", Stem Cell Rev Rep, 18, pp.2152~2163 (2022)[DOI]
  31. Gattinoni L, "COVID-19 does not lead to a"typical"acute respiratory distress syndrome", Am J Respir Crit Care Med, 201, pp.1299~1300 (2020)[DOI]
  32. Zhang Y, "Exosome : a review of its classification, isolation techniques, storage, diagnostic and targeted therapy applications", Int J Nanomedicine, 15, pp.6917~6934 (2020)[DOI]
  33. Théry C, "Isolation and characterization of exosomes from cell culture supernatants and biological fluids", Curr Protoc Cell Biol, 3 (2006)[DOI]
  34. Kowal J, "Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes", Proc Natl Acad Sci U S A, 113, pp.E968~E977 (2016)[DOI]
  35. Corsten MF, "Circulating microRNA-208b and microRNA-499 reflect myocardial damage in cardiovascular disease", Circ Cardiovasc Genet, 3, pp.499~506 (2010)[DOI]
  36. Zhang TR, "Angiogenic exosome-derived microRNAs : emerging roles in cardiovascular disease", J Cardiovasc Transl Res, 14, pp.824~840 (2021)[DOI]
  37. Heo J, "Exosome-based treatment for atherosclerosis", Int J Mol Sci, 23, pp.1002~ (2022)[DOI]
  38. Wang GK, "Circulating microRNA : a novel potential biomarker for early diagnosis of acute myocardial infarction in humans", Eur Heart J, 31, pp.659~666 (2010)[DOI]
  39. Dong X, "Serum exosomes can restore cellular function in vitro and be used for diagnosis in dysferlinopathy", Theranostics, 8, pp.1243~1255 (2018)[DOI]
  40. Goetzl EJ, "Low neural exosomal levels of cellular survival factors in Alzheimer’s disease", Ann Clin Transl Neurol, 2, pp.769~773 (2015)[DOI]
  41. Xu M, "Engineered exosomes : desirable target-tracking characteristics for cerebrovascular and neurodegenerative disease therapies", Theranostics, 11, pp.8926~8944 (2021)[DOI]
  42. Vella LJ, "Focus on extracellular vesicles : exosomes and their role in protein trafficking and biomarker potential in Alzheimer’s and Parkinson’s disease", Int J Mol Sci, 17, pp.173~ (2016)[DOI]
  43. Hannafon BN, "Plasma exosome microRNAs are indicative of breast cancer", Breast Cancer Res, 18, pp.90~ (2016)[DOI]
  44. Liang G, "Engineered exosomes for targeted co-delivery of miR-21 inhibitor and chemotherapeutics to reverse drug resistance in colon cancer", J Nanobiotechnology, 18, pp.10~ (2020)[DOI]
  45. Yan S, "Downregulation of circulating exosomal miR-638 predicts poor prognosis in colon cancer patients", Oncotarget, 8, pp.72220~72226 (2017)[DOI]
  46. Logozzi M, "High levels of exosomes expressing CD63 and caveolin-1 in plasma of melanoma patients", PLoS One, 4, pp.e5219~ (2009)[DOI]
  47. Heo JS, "Adipose-derived mesenchymal stem cells promote M2 macrophage phenotype through exosomes", Stem Cells Int, 2019, pp.7921760~ (2019)[DOI]
  48. Jeong JO, "Malignant tumor formation after transplantation of short-term cultured bone marrow mesenchymal stem cells in experimental myocardial infarction and diabetic neuropathy", Circ Res, 108, pp.1340~1347 (2011)[DOI]
  49. Maxson S, "Concise review : role of mesenchymal stem cells in wound repair", Stem Cells Transl Med, 1, pp.142~149 (2012)[DOI]
  50. Alexander M, "Exosome-delivered microRNAs modulate the inflammatory response to endotoxin", Nat Commun, 6, pp.7321~ (2015)[DOI]
  51. Zhou J, "LncGBP9", miR-34a axis drives macrophages toward a phenotype conducive for spinal cord injury repair via STAT1, J Neuroinflammation, pp.2020, 17[DOI]
  52. Domenis R, "Pro inflammatory stimuli enhance the immunosuppressive functions of adipose mesenchymal stem cells-derived exosomes", Sci Rep, 8, pp.13325~ (2018)[DOI]
  53. Serra MB, "From inflammation to current and alternative therapies involved in wound healing", Int J Inflam, 2017, pp.3406215~ (2017)[DOI]
  54. Bodnar RJ, "Chemokine regulation of angiogenesis during wound healing", Adv Wound Care, 4, pp.641~650 (2015)[DOI]
  55. Koh TJ, "Inflammation and wound healing: the role of the macrophage", Expert Rev Mol Med, 13, pp.e23~ (2011)[DOI]
  56. Heo JS, "Human adipose mesenchymal stem cell-derived exosomes : a key player in wound healing", Tissue Eng Regen Med, 18, pp.537~548 (2021)[DOI]
  57. Heo JS, "Selenium-stimulated exosomes enhance wound healing by modulating inflammation and angiogenesis", Int J Mol Sci, 23, pp.11543~ (2022)[DOI]
  58. Abraham A, "Mesenchymal stem cell-derived extracellular vesicles for the treatment of acute respiratory distress syndrome", Stem Cells Transl Med, 9, pp.28~38 (2020)[DOI]
  59. Worthington EN, "Therapeutic use of extracellular vesicles for acute and chronic lung disease", Int J Mol Sci, 21, pp.2318~ (2020)[DOI]
  60. Khatri M, "Mesenchymal stem cell-derived extracellular vesicles attenuate influenza virus-induced acute lung injury in a pig model", Stem Cell Res Ther, 9, pp.17~ (2018)[DOI]

관련 논문AI추천

Immunomodulatory effect of mesenchymal stem cells and mesenchymal stem-cell-derived exosomes for COVID-19 treatment이윤주, 임경민, 조쌍구, 아브달아메드, Arthi Kirubhakaran, Balachandar Vellingiri, Iyer Mahalaxmi, Jong Yub An, Kaavya Jayaramayya, Mohana Devi Subramaniam, Neethu Raj, Se Jong Kim, Yujin Choi생화학분자생물학회 · BMB Reports2020 · 제53권 제8호Therapeutic exosomes for various human diseases: Special issue of BMB Reports in 2022최철희생화학분자생물학회 · BMB Reports2022 · 제55권 제1호Mesenchymal Stem Cell-derived Exosomes: Applications in Cell-free Therapy김진관, 허준석대한임상검사과학회 · 대한임상검사과학회지2018 · 제50권 제4호Recent advances in extracellular vesicles for therapeutic cargo deliveryHan Yohan, Hyo In Kim, Park Jinbong, Wang Xiaoyun, Zhang Duo, Zhu Yin생화학분자생물학회 · Experimental and Molecular Medicine2024 · 제56권 Lipopolysaccharide로 자극한 RAW 264.7 세포에서 성체줄기세포 유래 엑소좀(exosome)의 면역 조절 효과구나연, 박미정, 변정수, 이지현, 정수경, 조인수, 차상호한국미생물·생명공학회 · 한국미생물·생명공학회지2016 · 제44권 제3호Exosome-Based Diagnostics: Emerging Tools for Early and Non-Invasive Disease Detection임은경, 정연우한국센서학회 · 센서학회지2025 · 제34권 제5호

이 간행물의 다른 논문 (11건)

The Workflow for Computational Analysis of Single-cell RNA-sequencing DataByung Chul JUNG, 우성훈pp. 10-20의료기사의 의료인 종별 포함에 관한 기초조사 연구: 한국, 일본, 대만을 중심으로Chang-Eun Park, Bon-Kyeong KOOpp. 21-31재채혈된 검체를 이용한 허용 Hemolysis Index에 대한 연구Yu Jin WOO, Dong Il Won, Hong Bum KIM, Kyoung Ae SON, Jin Man KIMpp. 32-42카세트 기반 자동합성장치를 사용한 [68Ga]Ga-FAPI-04의 합성방법 연구Won Jun KANG, Jun Young PARKpp. 43-51다이오드 레이저와 PhotoMed, Methyl Pheophorbide A, RadachlorinⓇ을 이용한 녹농균에 대한 항균 광역학 요법Keun-Dol YOOK, Young-Kyu SONG, Ji-Won KIMpp. 52-58
원문 보기